US Stock MarketDetailed Quotes
SMTI Sanara MedTech
- 31.875
- +0.365+1.16%
Trading May 22 12:40 ET
274.93MMarket Cap-54025P/E (TTM)
32.390High30.867Low6.41KVolume31.860Open31.510Pre Close202.86KTurnover0.19%Turnover RatioLossP/E (Static)8.63MShares46.40152wk High6.35P/B110.19MFloat Cap26.06052wk Low--Dividend TTM3.46MShs Float53.850Historical High--Div YieldTTM4.83%Amplitude17.410Historical Low31.642Avg Price1Lot Size
About Sanara MedTech Company
Sanara MedTech, Inc.engages in the development, marketing, and distribution of biotechnology products to physicians, hospitals, and clinics. It offers CellerateRX Surgical Activated Collagen Adjuvant and HemaQuell Resorbable Bone Hemostat. The company was founded in 1982 and is headquartered in Fort Worth, TX.
Company Profile
SymbolSMTI
Company NameSanara MedTech
Listing DateNov 2, 2020
Founded1982
CEOMr. Ronald T. Nixon
MarketNASDAQ
Employees108
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address1200 Summit Avenue,Suite 414
CityFort Worth
ProvinceTexas
CountryUnited States of America
Zip Code76102
Phone1-817-529-2300
Websitehttp://www.sanaramedtech.com
Company Executives
- Name
- Position
- Salary
- Ronald T. Nixon
- Executive Chairman of the Board and Chief Executive Officer
- 407.54K
- Michael D. McNeil
- Chief Financial Officer and Principal Accounting Officer
- 506.11K
- Jacob A. Waldrop
- Chief Operating Officer
- --
- Tyler Palmer
- Chief Corporate Development and Strategy Officer
- --
- Ann Beal Salamone, M.S.
- Director
- 261.58K
- Eric D. Major
- Independent Director
- 93.20K
- Roszell Mack, III
- Independent Director
- 97.85K
- Robert Andrew DeSutter
- Independent Director
- 102.53K
- James W. Stuckert
- Independent Director
- 97.85K
- Sara N. Ortwein
- Independent Director
- 97.85K
- Eric D. Tanzberger
- Independent Director
- 102.53K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg